HPBCD against acute and subacute infarcts in a mouse model of ischemic stroke
HPβCD has also been investigated as an active pharmaceutical ingredient (API) for the prospective treatment of ischemic stroke. We previously
A forum for researchers, students and applicants in the field of cyclodextrin technology
HPβCD has also been investigated as an active pharmaceutical ingredient (API) for the prospective treatment of ischemic stroke. We previously